{"url_path":"/sec/cldi/10-q/2026/item-1a","section_key":"item-1a","section_title":"Item 1A Risk Factors**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-023140-index.html","accession_number":"0001493152-26-023140","cik":"0001855485","ticker":"CLDI","issuer_name":"Calidi Biotherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-023140-index.html","primary_entity_key":"0001855485","primary_entity_name":"Calidi Biotherapeutics, Inc."},"word_count":54,"has_tables":true,"body_markdown":"**Item\n1A. Risk Factors**\n\n \n\nDuring\nthe three months ended March 31, 2026, there have been no material changes from the risk factors previously disclosed under the heading\n“Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, which was filed with\nthe SEC on March 27, 2026."}